10.1152/physrev.00034.2006 11
GLP-1 gastroparesis affects 4-fold more patients than placebo groups , with non-diabetic users facing 3.33 times higher risk than alternative weight loss treatments Short-acting GLP-1s cause more severe gastric slowing than long-acting versions , delaying emptying by 52 minutes versus 25 minutes respectively Retained gastric contents occur in 13.6% of GLP-1 users versus 2.3% of non-users , creating dangerous aspiration risks during medical procedures Most GLP-1 gastroparesis cases are reversible through tachyphylaxis , with gastric emptying effects diminishing within 4-6 weeks of continuous use Pre-procedural fasting protocols must be extended for GLP-1 users , holding daily medications on procedure day and weekly doses seven days before surgery The condition requires careful differentiation from functional dyspepsia and mechanical obstruction, as proper diagnosis directly impacts treatment outcomes
We finalized temporary reassignment of the cardiac CT codes (CPT codes 75572, 75573, and 75574) to APC 5572 (Level 2 Imaging with Contrast)
Women lost 11.1% of weight and men 7.5%
While it might not be widely discussed, it can feel unsettling if youre not expecting it
doi: 10.1186/s13058-020-01346-y 223 RuscettiMMorrisJP4MezzadraRRussellJLeiboldJRomesserPBet al
